Category:Cardiovascular Drugs
Jump to navigation
Jump to search
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Pages in category "Cardiovascular Drugs"
The following 200 pages are in this category, out of 929 total.
(previous page) (next page)A
- Abciximab
- Abciximab (patient information)
- Acebutolol
- Acenocoumarol
- Acetazolamide (extended-release capsule)
- Acetazolamide Oral (patient information)
- Acetyldigitoxin
- Acetyldigoxin
- Acetylsalicylic acid (patient information)
- Acipimox
- Acyclovir (patient information)
- Adenosine
- Ajmaline
- Alipogene tiparvovec
- Aliskiren
- Aloxiprin
- Alprenolol
- Alteplase (injection)
- Alteplase tissue plasminogen activator (patient information)
- Aluminium clofibrate
- Aluminium nicotinate
- Ambrisentan
- Amezinium metilsulfate
- Amiloride
- Amiloride and Hydrochlorothiazide (patient information)
- Amiodarone Oral (patient information)
- Amlodipine
- Amlodipine (patient information)
- Amlodipine adverse reactions
- Amlodipine clinical pharmacology
- Amlodipine clinical studies
- Amlodipine contraindications
- Amlodipine description
- Amlodipine dosage and administration
- Amlodipine dosage forms and strengths
- Amlodipine drug interactions
- Amlodipine how supplied storage and handling
- Amlodipine indications and usage
- Amlodipine labels and packages
- Amlodipine nonclinical toxicology
- Amlodipine overdosage
- Amlodipine patient counseling information
- Amlodipine use in specific populations
- Amlodipine warnings and precautions
- Ampicillin Oral (patient information)
- Ampicillin Sodium Injection (patient information)
- Amrinone
- Amyl nitrite
- Anagrelide (patient information)
- Ancrod
- Angiotensinamide
- Anisindione
- Anisindione (patient information)
- Anistreplase
- Anti-inhibitor coagulant complex
- Antihemophilic factor
- Antiplatelet therapy to support PCI
- Antithrombin III
- Apixaban
- Aprindine
- Arbutamine
- Argatroban
- Argatroban labels and packages
- Argatroban nonclinical toxicology
- Argatroban overdosage
- Argatroban patient counseling information
- Argatroban use in specific populations
- Argatroban warnings and precautions
- Aspirin (delayed release tablet)
- Aspirin (rectal)
- Atenolol
- Atenolol (patient information)
- Atenolol adverse reactions
- Atenolol clinical pharmacology
- Atenolol contraindications
- Atenolol description
- Atenolol dosage and administration
- Atenolol drug interactions
- Atenolol how supplied storage and handling
- Atenolol indications and usage
- Atenolol labels and packages
- Atenolol nonclinical toxicology
- Atenolol overdosage
- Atenolol use in specific populations
- Atenolol warnings and precautions
- Atorvastatin (patient information)
- Atorvastatin calcium
- Azapetine
- Azilsartan kamedoxomil
B
- Bamethan
- Barnidipine
- Bemiparin
- Benazepril
- Benazepril (patient information)
- Bencyclane
- Benidipine
- Benziodarone
- Bepridil
- Bepridil (patient information)
- Beraprost
- Betanidine
- Betaxolol (tablet)
- Betaxolol adverse reactions
- Betaxolol clinical pharmacology
- Betaxolol clinical studies
- Betaxolol contraindications
- Betaxolol description
- Betaxolol dosage and administration
- Betaxolol drug interactions
- Betaxolol how supplied storage and handling
- Betaxolol indications and usage
- Betaxolol nonclinical toxicology
- Betaxolol Ophthalmic (patient information)
- Betaxolol overdosage
- Betaxolol use in specific populations
- Betaxolol warnings and precautions
- Bevantolol
- Bezafibrate
- Bietaserpine
- Bisoprolol
- Bisoprolol (patient information)
- Bisoprolol adverse reactions
- Bisoprolol clinical pharmacology
- Bisoprolol clinical studies
- Bisoprolol contraindications
- Bisoprolol description
- Bisoprolol dosage and administration
- Bisoprolol drug interactions
- Bisoprolol how supplied storage and handling
- Bisoprolol indications and usage
- Bisoprolol labels and packages
- Bisoprolol nonclinical toxicology
- Bisoprolol overdosage
- Bisoprolol patient counseling information
- Bisoprolol use in specific populations
- Bisoprolol warnings and precautions
- Bivalirudin
- Bivalirudin adverse reactions
- Bivalirudin clinical pharmacology
- Bivalirudin clinical studies
- Bivalirudin contraindications
- Bivalirudin description
- Bivalirudin dosage and administration
- Bivalirudin dosage forms and strengths
- Bivalirudin drug interactions
- Bivalirudin how supplied storage and handling
- Bivalirudin indications and usage
- Bivalirudin labels and packages
- Bivalirudin nonclinical toxicology
- Bivalirudin overdosage
- Bivalirudin patient counseling information
- Bivalirudin use in specific populations
- Bivalirudin warnings and precautions
- Bosentan
- Brinase
- Bucladesine
- Buflomedil
- Bumetanide (injection)
- Bumetanide (patient information)
- Bunaftine
- Buphenine
- Bupranolol
- Butalamine
C
- Cafedrine
- Candesartan
- Candesartan (patient information)
- Canrenone
- Captopril
- Captopril (patient information)
- Captopril adverse reactions
- Captopril clinical pharmacology
- Captopril clinical studies
- Captopril contraindications
- Captopril description
- Captopril dosage and administration
- Captopril dosage forms and strengths
- Captopril drug interactions
- Captopril how supplied storage and handling
- Captopril indications and usage
- Captopril labels and packages
- Captopril nonclinical toxicology
- Captopril overdosage
- Captopril patient counseling information
- Captopril tablet
- Captopril use in specific populations
- Captopril warnings and precautions
- Carazolol
- Carbasalate calcium
- Carbocromen
- Carteolol (ophthalmic)
- Carteolol Oral (patient information)
- Carvedilol
- Carvedilol (patient information)
- Carvedilol adverse reactions
- Carvedilol clinical pharmacology
- Carvedilol clinical studies
- Carvedilol contraindications
- Carvedilol description
- Carvedilol dosage and administration
- Carvedilol dosage forms and strengths